Cellectis SA (CLLS)
1.85
-0.01
(-0.54%)
USD |
NASDAQ |
Nov 22, 12:40
Cellectis Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 95.69% |
| September 30, 2022 | -108.5% |
| June 30, 2022 | 74.81% |
| March 31, 2022 | 76.89% |
| December 31, 2021 | -84.97% |
| September 30, 2021 | -10.87% |
| June 30, 2021 | -5.18% |
| March 31, 2021 | 68.18% |
| December 31, 2020 | -80.49% |
| September 30, 2020 | -26.56% |
| June 30, 2020 | -100.9% |
| March 31, 2020 | 90.82% |
| December 31, 2019 | -28.42% |
| September 30, 2019 | 49.86% |
| June 30, 2019 | 29.25% |
| March 31, 2019 | 43.34% |
| Date | Value |
|---|---|
| December 31, 2018 | 16.80% |
| September 30, 2018 | 4.09% |
| June 30, 2018 | 88.93% |
| March 31, 2018 | 90.41% |
| December 31, 2017 | 84.89% |
| September 30, 2017 | 90.71% |
| June 30, 2017 | 91.33% |
| March 31, 2017 | 90.93% |
| December 31, 2016 | 92.33% |
| September 30, 2016 | 96.91% |
| June 30, 2016 | 98.16% |
| March 31, 2016 | 93.79% |
| December 31, 2015 | 95.10% |
| September 30, 2015 | 95.60% |
| June 30, 2015 | 94.65% |
| March 31, 2015 | 94.93% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-108.5%
Minimum
Sep 2022
95.69%
Maximum
Dec 2022
-3.04%
Average
-10.87%
Median
Sep 2021
Gross Profit Margin (Quarterly) Benchmarks
| Edap TMS SA | 39.35% |
| DBV Technologies SA | -- |
| Genfit SA | -- |
| Adaptimmune Therapeutics PLC | -- |
| Akari Therapeutics PLC | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -79.78% |
| Return on Assets | -24.83% |
| Return on Invested Capital | -57.78% |
| Profit Margin (Quarterly) | -142.3% |
| Operating Margin (Quarterly) | -66.49% |
| Return on Net Operating Assets | -43.66% |